State Of Wisconsin Investment Board Nektar Therapeutics Transaction History

State Of Wisconsin Investment Board

$36.2 Billion
Q2 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.64 - $3.15 $97,750 - $481,115	-152,735 Reduced 86.54%	23,757 $16,000
Q4 2022 Feb 14, 2023	SELL	$2.03 - $4.28 $22,999 - $48,492	-11,330 Reduced 6.03%	176,492 $398,000
Q3 2022 Nov 14, 2022	SELL	$3.04 - $5.14 $29,785 - $50,361	-9,798 Reduced 4.96%	187,822 $601,000
Q2 2022 Aug 15, 2022	BUY	$3.17 - $6.17 $99,461 - $193,589	31,376 Added 18.87%	197,620 $751,000
Q1 2022 May 13, 2022	BUY	$4.16 - $13.72 $599,988 - $1.98 Million	144,228 Added 655.11%	166,244 $896,000
Q4 2021 Feb 11, 2022	SELL	$10.83 - $18.41 $2,447 - $4,160	-226 Reduced 1.02%	22,016 $297,000
Q3 2021 Nov 12, 2021	BUY	$13.07 - $18.84 $13,736 - $19,800	1,051 Added 4.96%	22,242 $399,000
Q2 2021 Aug 12, 2021	SELL	$16.52 - $20.4 $13,001 - $16,054	-787 Reduced 3.58%	21,191 $364,000
Q1 2021 May 17, 2021	SELL	$16.56 - $25.46 $5,150 - $7,918	-311 Reduced 1.4%	21,978 $440,000
Q4 2020 Feb 03, 2021	SELL	$15.77 - $19.03 $14,823 - $17,888	-940 Reduced 4.05%	22,289 $379,000
Q3 2020 Nov 16, 2020	BUY	$16.59 - $24.79 $7,465 - $11,155	450 Added 1.98%	23,229 $385,000
Q2 2020 Aug 12, 2020	SELL	$16.86 - $23.44 $1.95 Million - $2.71 Million	-115,571 Reduced 83.54%	22,779 $528,000
Q1 2020 May 06, 2020	SELL	$14.47 - $27.96 $17,219 - $33,272	-1,190 Reduced 0.85%	138,350 $2.47 Million
Q4 2019 Feb 14, 2020	SELL	$15.87 - $23.12 $949,438 - $1.38 Million	-59,826 Reduced 30.01%	139,540 $3.01 Million
Q3 2019 Nov 12, 2019	BUY	$16.91 - $36.27 $214,198 - $459,432	12,667 Added 6.78%	199,366 $3.63 Million
Q2 2019 Aug 14, 2019	BUY	$31.0 - $36.3 $2.17 Million - $2.54 Million	70,037 Added 60.03%	186,699 $6.64 Million
Q1 2019 May 13, 2019	SELL	$31.58 - $46.35 $3.85 Million - $5.65 Million	-121,950 Reduced 51.11%	116,662 $3.92 Million
Q4 2018 Feb 11, 2019	BUY	$30.43 - $56.65 $503,799 - $937,897	16,556 Added 7.46%	238,612 $7.84 Million
Q3 2018 Nov 14, 2018	BUY	$46.46 - $68.49 $3.35 Million - $4.94 Million	72,196 Added 48.18%	222,056 $13.5 Million
Q2 2018 Aug 03, 2018	SELL	$46.25 - $104.45 $330,225 - $745,773	-7,140 Reduced 4.55%	149,860 $7.32 Million
Q1 2018 May 07, 2018	BUY	$57.4 - $108.44 $574,000 - $1.08 Million	10,000 Added 6.8%	157,000 $16.7 Million
Q4 2017 Feb 08, 2018	BUY	$23.02 - $60.5 $736,640 - $1.94 Million	32,000 Added 27.83%	147,000 $8.78 Million
Q3 2017 Nov 01, 2017	BUY	$17.79 - $24.0 $2.05 Million - $2.76 Million	115,000	115,000 $2.76 Million

Others Institutions Holding NKTR

# of Institutions

140

Shares Held

135M

Call Options Held

32.8K

Put Options Held

55.5K

Deep Track Capital, LP Greenwich, CT

17.9M
Shares

$23.2 Million
0.73% of portfolio
Black Rock Inc. New York, NY

15.2M
Shares

$19.7 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

13M
Shares

$16.9 Million
0.0% of portfolio
Samlyn Capital, LLC New York, NY

9.46M
Shares

$12.3 Million
0.21% of portfolio
Eventide Asset Management, LLC Boston, MA

7.53M
Shares

$9.79 Million
0.16% of portfolio

View Full List

About NEKTAR THERAPEUTICS

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $244M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

More about NKTR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wisconsin Investment Board with notifications on news.

Account